𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful use of adalimumab in treating cutaneous metastatic Crohn's disease: Report of a case

✍ Scribed by Faith A. Miller; Christopher R. Jones; Loren E. Clarke; Zenwu Lin; David R. Adams; Walter A. Koltun

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
78 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pityriasis lichenoides chronica induced
Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: Report of 2 cases successfully treated with methotrexate
✍ B. Ben Said; J. Kanitakis; I. Graber; J.F. Nicolas; J.C. Saurin; F. Berard πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

Tumor necrosis factor alpha (TNF-a) inhibitors improve inflammatory diseases such as Crohn's disease (CD). However, these biologicals may induce infections, neoplasms, or autoimmune diseases. Cutaneous side effects have been reported, including dermatitis, psoriasis-like rash, and vasculitis. 1 We r

Lewis and Sumner syndrome following infl
Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases
✍ Stephane Nancey; FranΓ§oise Bouhour; Gilles Boschetti; Christophe Magnier; Pierre πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o